Preveceutical Medical Inc (CNSX:PREV) traded up 11.1% during mid-day trading on Thursday . The company traded as high as $0.05 and last traded at $0.05, 442,075 shares changed hands during mid-day trading. The stock had previously closed at $0.05.
The company has a 50-day moving average of $0.05.
Preveceutical Medical Company Profile (CNSX:PREV)
PreveCeutical Medical Inc, a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions.
Further Reading: Overbought
Receive News & Ratings for Preveceutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Preveceutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.